West Pharmaceutical Services Inc.

WST | NYSE

$413.79

+$1.17 (+0.28%)

Nov 2, 2026, 12:03 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	493.7M	492.7M	593.4M	585.9M	661.8M	346.2M
Depreciation & Amortization	171.4M	155.4M	137.3M	120.6M	122.3M	109.1M
Stock-Based Compensation	23.8M	18.7M	23.3M	23.7M	37.5M	34M
Other Working Capital	117.8M	16.8M	-15.3M	73.2M	-600K	73.4M
Other Non-Cash Items	-200K	-16.3M	5.4M	36.1M	-900K	-700K
Deferred Income Tax	-13.7M	n/a	37.5M	-30.8M	-42.9M	-5.8M
Change in Working Capital	79.8M	2.9M	-20.4M	-15M	-193.8M	-10.3M
Operating Cash Flow	754.8M	653.4M	776.5M	724M	584M	472.5M
Capital Expenditures	-285.9M	-377M	-362M	-284.6M	-253.4M	-174.4M
Cash Acquisitions	n/a	n/a	n/a	n/a	-2.2M	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	-1.7M	-6.7M	-3.6M	2.5M	-5.1M
Investing Cash Flow	-285.9M	-378.7M	-368.7M	-288.2M	-253.1M	-179.5M
Debt Repayment	-1.1M	-27.6M	-2.3M	-44.3M	-2.2M	-2.3M
Common Stock Repurchased	-134M	-566.6M	-451.2M	-222.2M	-151.9M	-121.4M
Dividend Paid	-61.2M	-59.1M	-57M	-54.1M	-51.1M	-48.1M
Other Financial Acitivies	-7M	30.7M	50.9M	27M	37.1M	34.7M
Financial Cash Flow	-185.1M	-622.6M	-459.6M	-293.6M	-168.1M	-137.1M
Net Cash Flow	306.7M	-369.3M	-40.4M	131.7M	147.1M	176.4M
Free Cash Flow	468.9M	276.4M	414.5M	439.4M	330.6M	298.1M
Adj. Free Cash Flow	445.1M	257.7M	391.2M	415.7M	293.1M	264.1M
Maintenance CapEx	-195.01M	-377M	-331.2M	-259.09M	n/a	-23.26M
Growth CapEx	-90.89M	n/a	-30.8M	-25.51M	-253.4M	-151.14M
Owner Earnings	559.79M	276.4M	445.3M	464.91M	584M	449.24M